Brief: Silo Pharma Initiates Study Of Novel Joint Homing Peptide In Human Tissue
21/11/2022 12:47
Nov 21 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA INITIATES STUDY OF NOVEL JOINT HOMING PEPTIDE
IN
HUMAN TISSUE
* SILO PHARMA INC - INITIAL DATA FROM STUDY EXPECTED IN Q1
2023
* SILO PHARMA INC - INITIAL DATA FROM STUDY IS EXPECTED
DURING Q1
OF 2023
* SILO PHARMA INC - THREE-MONTH STUDY WILL ASSESS BINDING
AFFINITY
OF PEPTIDE IN HEALTHY HUMAN AND RA SYNOVIAL TISSUE
Source text for Eikon: ID:nGNXb2wvcB
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement